Prevalence, investigational pathways and diagnostic outcomes in differing irritable bowel syndrome subtypes

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 10, 2014, Pages 1176-1180

  Lin, Simone ^a   Mooney, Peter D ^a   Kurien, Matthew ^a   Aziz, Imran ^a   Leeds, John S ^a   Sanders, David S ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Irritable bowel syndrome; Prevalence; Rome criteria

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONSTIPATION; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC VALUE; DIARRHEA; DIVERTICULOSIS; FEMALE; HUMAN; HYDROGEN BREATH TEST; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; PANCREAS INSUFFICIENCY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; ROME III DIAGNOSTIC QUESTIONNAIRE; VERY ELDERLY; CASE CONTROL STUDY; CLASSIFICATION; CLINICAL PATHWAY; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM EXAMINATION; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; PREDICTIVE VALUE; PROGNOSIS; UNITED KINGDOM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CONSTIPATION; CRITICAL PATHWAYS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, DIGESTIVE SYSTEM; DIARRHEA; ENGLAND; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; YOUNG ADULT;

EID: 84927698743     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000171     Document Type: Article

References (33)

1. Andrews EB, Eaton SC, Hollis KA, Hopkins JS, Ameen V, Hamm LR, et al. Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey. Aliment Pharmacol Ther 2005; 22:935-942.
2. Wilson S, Roberts L, Roalfe A, Bridge P, Singh S. Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract 2004; 54:495-502.
3. Grundmann O, Yoon SL. Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners. J Gastroenterol Hepatol 2010; 25:691-699.
4. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005; 100:1174-1184.
5. Map of Medicine. Irritable bowel syndrome (IBS). International View (issue 1). London: Map of Medicine; 2012.
6. Ford AC, Talley NJ. Irritable bowel syndrome. BMJ 2012; 345:e5836.
7. National Institute for Health and Care Excellence. Irritable bowel syndrome: diagnosis and management of irritable bowel syndrome in primary care. Clinical guideline 61. London: National Institute for Health and Care Excellence; 2008.
8. Leeds JS, Hopper AD, Sidhu R, Simmonette A, Azadbakht N, Hoggard N, et al. Some patients with irritable bowel syndrome may have exocrine pancreatic insufficiency. Clin Gastroenterol Hepatol 2010; 8:433-438.
9. Wedlake L, A'Hern R, Russell D, Thomas K, Walters JRF, Andreyev HJN. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009; 30:707-717.
10. Ford AC, Spiegel BMR, Talley NJ, Moayyedi P. Small intestinal bacterial overgrowth in irritable bowel syndrome: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009; 7:1279-1286.
11. Sanders DS, Patel D, Stephenson TJ, Ward AM, McCloskey EV, Hadjivassiliou M, Lobo AJ. A primary care cross-sectional study of undiagnosed adult coeliac disease. Eur J Gastroenterol Hepatol 2003; 15:407-413.
12. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130:1377-1390.
13. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304:87-90.
14. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40 000 subjects. Aliment Pharmacol Ther 2003; 17:643-650.
15. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10:712-721.
16. Mearin F, Baró E, Roset M, Badía X, Zárate N, Pérez I. Clinical patterns over time in irritable bowel syndrome: symptom instability and severity variability. Am J Gastroenterol 2004; 99:113-121.
17. Ersryd A, Posserud I, Abrahamsson H, Simrén M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther 2007; 26:953-961.
18. Ford AC, Bercik P, Morgan DG, Bolino C, Pintos-Sanchez MI, Moayyedi P. Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther 2014; 39:312-321.
19. Gallagher P, O'Mahony D. Constipation in old age. Best Pract Res Clin Gastroenterol 2009; 23:875-887.
20. Britton E, McLaughlin JT. Ageing and the gut. Proc Nutr Soc 2013; 72:173-177.
21. Spiller R, Aziz Q, Creed F, Emmanuel A, Houghton L, Hungin P, et al. Clinical Services Committee of The British Society of Gastroenterology. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut 2007; 56:1770-1798.
22. Malagelada JR. A symptom-based approach to making a positive diagnosis of irritable bowel syndrome with constipation. Int J Clin Pract 2006; 60:57-63.
23. Suares NC, Ford AC. Diagnosis and treatment of irritable bowel syndrome. Discov Med 2011; 11:425-433.
24. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002; 97:2812-2819.
25. Hamm LR, Sorrells SC, Harding JP, Northcutt AR, Heath AT, Kapke GF, et al. Additional investigations fail to alter the diagnosis of irritable bowel syndrome in subjects fulfilling the Rome criteria. Am J Gastroenterol 1999; 94:1279-1282.
26. Tolliver BA, Herrera JL, DiPalma JA. Evaluation of patients who meet clinical criteria for irritable bowel syndrome. Am J Gastroenterol 1994; 89:176-178.
27. Cash BD, Chey WD. Irritable bowel syndrome - an evidence-based approach to diagnosis. Aliment Pharmacol Ther 2004; 19:1235-1245.
28. Sanders DS, Carter MJ, Hurlstone DP, Pearce A, Ward AM, McAlindon ME, Lobo AJ. Association of adult coeliac disease with irritable bowel syndrome: a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001; 358:1504-1508.
29. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BMR, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009; 169:651-658.
30. Brandt LJ, Chey WD, Foxx-Orenstein AE, Schiller LR, Schoenfeld PS, Spiegel BM, et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009; 104 (Suppl):S1-S35.
31. Gracie DJ, Kane JS, Mumtaz S, Scarsbrook AF, Chowdhury FU, Ford AC. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhoea. Neurogastroenterol Motil 2012; 24:983-e538.
32. Lupascu A, Gabrielli M, Lauritano EC, Scarpellini E, Santoliquido A, Cammarota G, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-controlled study in irritable bowel syndrome. Aliment Pharmacol Ther 2005; 22:1157-1160.
33. Rana SV, Sinha SK, Sikander A, Bhasin DK, Singh K. Study of small intestinal bacterial overgrowth in North Indian patients with irritable bowel syndrome: a case controlled study. Trop Gastroenterol 2008; 29:23-25.